BridgeMD
New treatment option for Primary Ciliary Dyskinesia
Official title Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
ClinicalTrials.gov ID: NCT07288827
What this study is testing
- What it's testing
- The purpose of this study is to look at children with PCD and see if they have another condition called "bronchial hyperresponsiveness".
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 and older. Healthy volunteers may be eligible.
You may be able to join if
- Confirmed diagnosis of PCD per standard diagnostic criteria4 and positive genetics
- Age greater than or equal to 6 years (no upper age limit)
- Any gender or race
- Able to perform pulmonary function testing (historical documentation of reversibility will be accepted)
You likely can't join if
- history of current pneumothorax
- inability to perform pulmonary function testing
The study team makes the final eligibility decision.
Where it's taking place
- Indianapolis, Indiana, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Indianapolis, Indiana, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.